Status:
COMPLETED
Fecal Calprotectin: Cheap Marker for Diagnosing Acute Infectious Diarrhea
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Acute Diarrhea
Eligibility:
All Genders
18+ years
Brief Summary
Every year more than 4 billion cases of diarrhea occur worldwide culminating in about 2.5 million deaths, almost all in the developing nations. Reliable diagnosis of patients with acute infectious dia...
Detailed Description
There are about 4 billion cases of diarrhea worldwide i.e. about half the population of the world is affected with it once every year. Though the mortality because of it has reduced significantly stil...
Eligibility Criteria
Inclusion
- All patients having acute diarrhea i.e. 3 or more stools per day or stool weight exceeding 200 grams lasting less than 15 days
Exclusion
- Patients having the following diagnosis as they might have high calprotectin levels not only because of the diarrhea per se but may also be because of the underlying pathology itself.
- Inflammatory bowel disease (Crohn's disease, ulcerative disease)
- Gastrointestinal malignancy (colorectal cancer, gastric cancer etc)
- Cirrhosis of liver
- Chronic pancreatitis
- Currently on non steroidal anti inflammatory therapy
- Younger than 1 year of age
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
End Date :
January 1 2007
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00429325
Start Date
January 1 2004
End Date
January 1 2007
Last Update
July 17 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory Walther, Weindel & Colleagues
Frankfurt am Main, Hesse, Germany, D 60437
2
Department of Medicine I, Division of Gastroenterology and Clinical Nutrition, Johann Wolfgang Goethe-University Hospital
Frankfurt am Main, Hesse, Germany, D-60590